Monash did the trial and came up with the 300% not GPP.
The concentration does matter......it needs to be the same for all trials.
GPP could have said nothing......but I suspect the cock up was recognised by Monash and GPP management had no option but tell the truth. Last bit is an educated guess.
We need some field trials to answer the big questions.....but they can't happen for a year.....at least in this hemisphere. DB
GPP Price at posting:
0.4¢ Sentiment: None Disclosure: Held
